Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $190
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has reiterated its Buy rating on Tenet Healthcare and increased the price target from $180 to $190.
October 30, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has reiterated its Buy rating on Tenet Healthcare and increased the price target from $180 to $190, indicating confidence in the company's future performance.
The reiteration of a Buy rating and an increased price target from a reputable analyst can positively influence investor sentiment and potentially lead to a short-term increase in the stock price of Tenet Healthcare.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100